Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › New York › Albany
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Albany, NY keessatti
Qorannoo 9 Kansara Qara'a Non-Small Cell f Albany fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Namoota walitti qabaa jiraSadarkaa 3
- New York Oncology Hematology, P.C. ( Site 0132), Albany
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Namoota walitti qabaa jiraSadarkaa 3
- New York Oncology Hematology, P.C. ( Site 0119), Albany
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Namoota walitti qabaa jiraSadarkaa 3
- New York Oncology Hematology, P.C. ( Site 9000), Albany
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Namoota walitti qabaa jiraSadarkaa 3
- New York Oncology Hematology P.C ( Site 9000), Albany
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- New York Oncology Hematology, Albany
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Namoota walitti qabaa jiraSadarkaa 2/3
- New York Oncology Hematology - Albany Medical Center, Albany
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2
- ONE Onc: New York Oncology Hematology, Albany
MYLUNG Consortium Part 3: Observational Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- New York Oncology Hematology, P.C., Albany
GEMINI-NSCLC: NSCLC Biomarker Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- New York Oncology Hematology, Albany
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Albany keessatti
- Dhibee Onneessaa fi DhiigaQorannoo 7
- Cufama OnneeQorannoo 6
- ObesityQorannoo 6
- Saree (Gosoota Hunda)Qorannoo 5
- StrokeQorannoo 4
- Dhiibbaa Dhiigaa Ol'aanaaQorannoo 4
- Burkitt LymphomaQorannoo 4
- Myeloma Baay’eeQorannoo 4
- Dhukkubaa AlzheimerQorannoo 4
- Dhukkuboota HidhooQorannoo 4
- Dukkana BladderQorannoo 4
- Saree OljooQorannoo 4
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.